nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Glutamine—QARS—Cytosolic tRNA aminoacylation—TARS—psoriasis	0.0473	0.216	CbGpPWpGaD
L-Glutamine—TGM1—skin epidermis—psoriasis	0.0411	0.171	CbGeAlD
L-Glutamine—QARS—tRNA Aminoacylation—TARS—psoriasis	0.0303	0.138	CbGpPWpGaD
L-Glutamine—TGM2—endothelium—psoriasis	0.0219	0.091	CbGeAlD
L-Glutamine—SLC7A8—skin epidermis—psoriasis	0.0169	0.0705	CbGeAlD
L-Glutamine—TGM5—skin of body—psoriasis	0.0158	0.0655	CbGeAlD
L-Glutamine—TGM1—skin of body—psoriasis	0.0127	0.053	CbGeAlD
L-Glutamine—CTPS1—Mycophenolic acid—Mycophenolate mofetil—psoriasis	0.0125	0.864	CbGdCrCtD
L-Glutamine—TGM3—skin of body—psoriasis	0.0119	0.0497	CbGeAlD
L-Glutamine—TGM2—skin of body—psoriasis	0.00934	0.0388	CbGeAlD
L-Glutamine—CCBL1—tendon—psoriasis	0.00763	0.0317	CbGeAlD
L-Glutamine—GATB—tendon—psoriasis	0.00763	0.0317	CbGeAlD
L-Glutamine—QARS—skin of body—psoriasis	0.00736	0.0306	CbGeAlD
L-Glutamine—TGM2—Alpha9 beta1 integrin signaling events—NOS2—psoriasis	0.00721	0.0329	CbGpPWpGaD
L-Glutamine—GLS—tendon—psoriasis	0.00719	0.0299	CbGeAlD
L-Glutamine—PFAS—Purine metabolism—CAT—psoriasis	0.0071	0.0324	CbGpPWpGaD
L-Glutamine—GMPS—Purine metabolism—CAT—psoriasis	0.0071	0.0324	CbGpPWpGaD
L-Glutamine—GMPS—tendon—psoriasis	0.00669	0.0278	CbGeAlD
L-Glutamine—CTPS1—tendon—psoriasis	0.00669	0.0278	CbGeAlD
L-Glutamine—PFAS—tendon—psoriasis	0.00657	0.0273	CbGeAlD
L-Glutamine—GFPT2—tendon—psoriasis	0.00657	0.0273	CbGeAlD
L-Glutamine—F13A1—tendon—psoriasis	0.0059	0.0245	CbGeAlD
L-Glutamine—SLC1A5—skin of body—psoriasis	0.00583	0.0243	CbGeAlD
L-Glutamine—QARS—tendon—psoriasis	0.0056	0.0233	CbGeAlD
L-Glutamine—SLC7A8—skin of body—psoriasis	0.00525	0.0218	CbGeAlD
L-Glutamine—CAD—tendon—psoriasis	0.00517	0.0215	CbGeAlD
L-Glutamine—F13A1—Alpha9 beta1 integrin signaling events—NOS2—psoriasis	0.00487	0.0222	CbGpPWpGaD
L-Glutamine—PPAT—tendon—psoriasis	0.00479	0.0199	CbGeAlD
L-Glutamine—SLC1A5—tendon—psoriasis	0.00444	0.0185	CbGeAlD
L-Glutamine—PPAT—Purine metabolism—CAT—psoriasis	0.00419	0.0191	CbGpPWpGaD
L-Glutamine—TGM2—Alpha9 beta1 integrin signaling events—VEGFA—psoriasis	0.00417	0.019	CbGpPWpGaD
L-Glutamine—GLUL—skin of body—psoriasis	0.00409	0.017	CbGeAlD
L-Glutamine—CTPS1—Nucleotide metabolism—CAT—psoriasis	0.004	0.0183	CbGpPWpGaD
L-Glutamine—SLC7A8—tendon—psoriasis	0.004	0.0166	CbGeAlD
L-Glutamine—TGM2—Thromboxane A2 receptor signaling—ICAM1—psoriasis	0.00381	0.0174	CbGpPWpGaD
L-Glutamine—ASNS—tendon—psoriasis	0.00381	0.0158	CbGeAlD
L-Glutamine—L-Arginine—NOS2—psoriasis	0.0038	0.54	CrCbGaD
L-Glutamine—F13A1—Hemostasis—SERPINB8—psoriasis	0.00368	0.0168	CbGpPWpGaD
L-Glutamine—PFAS—Nucleotide metabolism—CAT—psoriasis	0.00357	0.0163	CbGpPWpGaD
L-Glutamine—GMPS—Nucleotide metabolism—CAT—psoriasis	0.00357	0.0163	CbGpPWpGaD
L-Glutamine—L-Citrulline—NOS2—psoriasis	0.00323	0.46	CrCbGaD
L-Glutamine—GLUL—tendon—psoriasis	0.00311	0.0129	CbGeAlD
L-Glutamine—F13A1—Alpha9 beta1 integrin signaling events—VEGFA—psoriasis	0.00282	0.0129	CbGpPWpGaD
L-Glutamine—SLC16A10—tendon—psoriasis	0.00237	0.00987	CbGeAlD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—REL—psoriasis	0.00237	0.0108	CbGpPWpGaD
L-Glutamine—CAD—Nucleotide metabolism—CAT—psoriasis	0.0023	0.0105	CbGpPWpGaD
L-Glutamine—SLC7A8—Cell surface interactions at the vascular wall—ITGAL—psoriasis	0.00227	0.0103	CbGpPWpGaD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—TNFRSF1B—psoriasis	0.00224	0.0102	CbGpPWpGaD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—TNFAIP3—psoriasis	0.00215	0.00983	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—TARS—psoriasis	0.00215	0.00983	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—SERPINB8—psoriasis	0.00212	0.00965	CbGpPWpGaD
L-Glutamine—PPAT—Nucleotide metabolism—CAT—psoriasis	0.0021	0.0096	CbGpPWpGaD
L-Glutamine—ASNS—ATF4 activates genes—CXCL8—psoriasis	0.0021	0.0096	CbGpPWpGaD
L-Glutamine—ASNS—PERK regulates gene expression—CXCL8—psoriasis	0.00192	0.00876	CbGpPWpGaD
L-Glutamine—TGM2—Beta1 integrin cell surface interactions—VEGFA—psoriasis	0.00192	0.00876	CbGpPWpGaD
L-Glutamine—SLC1A5—SLC-mediated transmembrane transport—CP—psoriasis	0.00161	0.00734	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—NDUFA5—psoriasis	0.00142	0.0065	CbGpPWpGaD
L-Glutamine—SLC38A3—SLC-mediated transmembrane transport—CP—psoriasis	0.00137	0.00624	CbGpPWpGaD
L-Glutamine—PPAT—Fluoropyrimidine Activity—TP53—psoriasis	0.00133	0.00605	CbGpPWpGaD
L-Glutamine—F13A1—Beta1 integrin cell surface interactions—VEGFA—psoriasis	0.0013	0.00592	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—NDUFA5—psoriasis	0.00127	0.00579	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—NDUFA5—psoriasis	0.00127	0.00579	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—CYP2S1—psoriasis	0.00121	0.00553	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—NDUFA5—psoriasis	0.00116	0.0053	CbGpPWpGaD
L-Glutamine—F13A1—Platelet degranulation—VEGFA—psoriasis	0.00111	0.00507	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—CYP2S1—psoriasis	0.00108	0.00493	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—CYP2S1—psoriasis	0.00108	0.00493	CbGpPWpGaD
L-Glutamine—GFPT2—Metabolism of proteins—REN—psoriasis	0.00107	0.00489	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—ITGAL—psoriasis	0.00107	0.00488	CbGpPWpGaD
L-Glutamine—F13A1—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	0.00106	0.00483	CbGpPWpGaD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—NFKBIA—psoriasis	0.00104	0.00475	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—NDUFA5—psoriasis	0.00101	0.00463	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—NDUFA5—psoriasis	0.00101	0.00463	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—NDUFA5—psoriasis	0.00101	0.00463	CbGpPWpGaD
L-Glutamine—SLC7A8—SLC-mediated transmembrane transport—CP—psoriasis	0.00101	0.00461	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—CYP2S1—psoriasis	0.000987	0.00451	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—CYP2S1—psoriasis	0.000863	0.00394	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—CYP2S1—psoriasis	0.000863	0.00394	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—CYP2S1—psoriasis	0.000863	0.00394	CbGpPWpGaD
L-Glutamine—ASNS—Unfolded Protein Response (UPR)—CXCL8—psoriasis	0.000846	0.00386	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—NDUFA5—psoriasis	0.000818	0.00373	CbGpPWpGaD
L-Glutamine—SLC1A5—Transmembrane transport of small molecules—CP—psoriasis	0.000818	0.00373	CbGpPWpGaD
L-Glutamine—SLC1A5—Transmembrane transport of small molecules—CARM1—psoriasis	0.00078	0.00356	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—NDUFA5—psoriasis	0.000748	0.00341	CbGpPWpGaD
L-Glutamine—CAD—Validated targets of C-MYC transcriptional activation—TP53—psoriasis	0.000721	0.00329	CbGpPWpGaD
L-Glutamine—CAD—Levonorgestrel—Hydrocortisone—psoriasis	0.000708	0.049	CbGdCrCtD
L-Glutamine—CAD—Metabolism—CYP2S1—psoriasis	0.000696	0.00317	CbGpPWpGaD
L-Glutamine—SLC38A3—Transmembrane transport of small molecules—CP—psoriasis	0.000695	0.00317	CbGpPWpGaD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—JUN—psoriasis	0.000689	0.00315	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—CARM1—psoriasis	0.000678	0.00309	CbGpPWpGaD
L-Glutamine—GFPT2—Metabolism of proteins—ACE—psoriasis	0.000669	0.00305	CbGpPWpGaD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—NFKB1—psoriasis	0.000664	0.00303	CbGpPWpGaD
L-Glutamine—SLC38A3—Transmembrane transport of small molecules—CARM1—psoriasis	0.000663	0.00303	CbGpPWpGaD
L-Glutamine—Hypersensitivity—Hydroxyurea—psoriasis	0.000655	0.00126	CcSEcCtD
L-Glutamine—Malaise—Mycophenolate mofetil—psoriasis	0.000649	0.00125	CcSEcCtD
L-Glutamine—Fatigue—Mycophenolic acid—psoriasis	0.000642	0.00124	CcSEcCtD
L-Glutamine—Asthenia—Hydroxyurea—psoriasis	0.000638	0.00123	CcSEcCtD
L-Glutamine—PFAS—Levonorgestrel—Hydrocortisone—psoriasis	0.000638	0.0441	CbGdCrCtD
L-Glutamine—Pain—Mycophenolic acid—psoriasis	0.000637	0.00123	CcSEcCtD
L-Glutamine—Constipation—Mycophenolic acid—psoriasis	0.000637	0.00123	CcSEcCtD
L-Glutamine—PPAT—Metabolism—CYP2S1—psoriasis	0.000636	0.0029	CbGpPWpGaD
L-Glutamine—Myalgia—Cyclosporine—psoriasis	0.000628	0.00121	CcSEcCtD
L-Glutamine—Arthralgia—Cyclosporine—psoriasis	0.000628	0.00121	CcSEcCtD
L-Glutamine—Chest pain—Cyclosporine—psoriasis	0.000628	0.00121	CcSEcCtD
L-Glutamine—Ill-defined disorder—Prednisolone—psoriasis	0.000623	0.0012	CcSEcCtD
L-Glutamine—Depression—Prednisone—psoriasis	0.000623	0.0012	CcSEcCtD
L-Glutamine—Discomfort—Cyclosporine—psoriasis	0.000621	0.0012	CcSEcCtD
L-Glutamine—CTPS1—Levonorgestrel—Hydrocortisone—psoriasis	0.000619	0.0428	CbGdCrCtD
L-Glutamine—Dry mouth—Cyclosporine—psoriasis	0.000615	0.00118	CcSEcCtD
L-Glutamine—SLC7A8—Hemostasis—ITGAL—psoriasis	0.000614	0.0028	CbGpPWpGaD
L-Glutamine—Feeling abnormal—Mycophenolic acid—psoriasis	0.000614	0.00118	CcSEcCtD
L-Glutamine—Myalgia—Mycophenolate mofetil—psoriasis	0.000613	0.00118	CcSEcCtD
L-Glutamine—Arthralgia—Mycophenolate mofetil—psoriasis	0.000613	0.00118	CcSEcCtD
L-Glutamine—Chest pain—Mycophenolate mofetil—psoriasis	0.000613	0.00118	CcSEcCtD
L-Glutamine—Neuropathy peripheral—Prednisone—psoriasis	0.000612	0.00118	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Mycophenolic acid—psoriasis	0.000609	0.00117	CcSEcCtD
L-Glutamine—Ill-defined disorder—Hydrocortisone—psoriasis	0.000609	0.00117	CcSEcCtD
L-Glutamine—Malaise—Prednisolone—psoriasis	0.000606	0.00117	CcSEcCtD
L-Glutamine—Discomfort—Mycophenolate mofetil—psoriasis	0.000606	0.00117	CcSEcCtD
L-Glutamine—Oedema—Cyclosporine—psoriasis	0.000602	0.00116	CcSEcCtD
L-Glutamine—Dry mouth—Mycophenolate mofetil—psoriasis	0.0006	0.00116	CcSEcCtD
L-Glutamine—Infection—Cyclosporine—psoriasis	0.000599	0.00115	CcSEcCtD
L-Glutamine—Back pain—Triamcinolone—psoriasis	0.000598	0.00115	CcSEcCtD
L-Glutamine—Malaise—Hydrocortisone—psoriasis	0.000592	0.00114	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—CARM1—psoriasis	0.000591	0.0027	CbGpPWpGaD
L-Glutamine—Body temperature increased—Mycophenolic acid—psoriasis	0.000589	0.00113	CcSEcCtD
L-Glutamine—Abdominal pain—Mycophenolic acid—psoriasis	0.000589	0.00113	CcSEcCtD
L-Glutamine—Dizziness—Hydroxyurea—psoriasis	0.000588	0.00113	CcSEcCtD
L-Glutamine—Oedema—Mycophenolate mofetil—psoriasis	0.000588	0.00113	CcSEcCtD
L-Glutamine—SLC16A10—SLC-mediated transmembrane transport—CP—psoriasis	0.000586	0.00267	CbGpPWpGaD
L-Glutamine—Angiopathy—Betamethasone—psoriasis	0.000584	0.00113	CcSEcCtD
L-Glutamine—Angiopathy—Dexamethasone—psoriasis	0.000584	0.00113	CcSEcCtD
L-Glutamine—Infection—Mycophenolate mofetil—psoriasis	0.000584	0.00113	CcSEcCtD
L-Glutamine—ASNS—Metabolism—NDUFA5—psoriasis	0.000583	0.00266	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—NDUFA5—psoriasis	0.000583	0.00266	CbGpPWpGaD
L-Glutamine—Hyperhidrosis—Cyclosporine—psoriasis	0.000582	0.00112	CcSEcCtD
L-Glutamine—ASNS—Metabolism of proteins—REN—psoriasis	0.000579	0.00264	CbGpPWpGaD
L-Glutamine—Pancreatitis—Methotrexate—psoriasis	0.000574	0.00111	CcSEcCtD
L-Glutamine—Ill-defined disorder—Triamcinolone—psoriasis	0.000573	0.0011	CcSEcCtD
L-Glutamine—Hyperhidrosis—Mycophenolate mofetil—psoriasis	0.000568	0.00109	CcSEcCtD
L-Glutamine—Vomiting—Hydroxyurea—psoriasis	0.000565	0.00109	CcSEcCtD
L-Glutamine—Discomfort—Prednisolone—psoriasis	0.000565	0.00109	CcSEcCtD
L-Glutamine—Rash—Hydroxyurea—psoriasis	0.000561	0.00108	CcSEcCtD
L-Glutamine—Dermatitis—Hydroxyurea—psoriasis	0.00056	0.00108	CcSEcCtD
L-Glutamine—Myalgia—Hydrocortisone—psoriasis	0.000559	0.00108	CcSEcCtD
L-Glutamine—Malaise—Triamcinolone—psoriasis	0.000557	0.00107	CcSEcCtD
L-Glutamine—Headache—Hydroxyurea—psoriasis	0.000557	0.00107	CcSEcCtD
L-Glutamine—Discomfort—Hydrocortisone—psoriasis	0.000552	0.00106	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.000549	0.00106	CcSEcCtD
L-Glutamine—Oedema—Prednisolone—psoriasis	0.000548	0.00106	CcSEcCtD
L-Glutamine—Insomnia—Cyclosporine—psoriasis	0.000545	0.00105	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.000535	0.00103	CcSEcCtD
L-Glutamine—Oedema—Hydrocortisone—psoriasis	0.000535	0.00103	CcSEcCtD
L-Glutamine—Asthenia—Mycophenolic acid—psoriasis	0.000534	0.00103	CcSEcCtD
L-Glutamine—Infection—Hydrocortisone—psoriasis	0.000532	0.00102	CcSEcCtD
L-Glutamine—Insomnia—Mycophenolate mofetil—psoriasis	0.000532	0.00102	CcSEcCtD
L-Glutamine—Hyperhidrosis—Prednisolone—psoriasis	0.00053	0.00102	CcSEcCtD
L-Glutamine—Nausea—Hydroxyurea—psoriasis	0.000528	0.00102	CcSEcCtD
L-Glutamine—GMPS—Metabolism—CARM1—psoriasis	0.000527	0.00241	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—CARM1—psoriasis	0.000527	0.00241	CbGpPWpGaD
L-Glutamine—Pruritus—Mycophenolic acid—psoriasis	0.000527	0.00102	CcSEcCtD
L-Glutamine—Myalgia—Triamcinolone—psoriasis	0.000526	0.00101	CcSEcCtD
L-Glutamine—Depression—Methotrexate—psoriasis	0.00052	0.001	CcSEcCtD
L-Glutamine—Ill-defined disorder—Betamethasone—psoriasis	0.00052	0.001	CcSEcCtD
L-Glutamine—Ill-defined disorder—Dexamethasone—psoriasis	0.00052	0.001	CcSEcCtD
L-Glutamine—Discomfort—Triamcinolone—psoriasis	0.00052	0.001	CcSEcCtD
L-Glutamine—Fatigue—Cyclosporine—psoriasis	0.000519	0.001	CcSEcCtD
L-Glutamine—Hyperhidrosis—Hydrocortisone—psoriasis	0.000518	0.000997	CcSEcCtD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—TNF—psoriasis	0.000516	0.00236	CbGpPWpGaD
L-Glutamine—Constipation—Cyclosporine—psoriasis	0.000515	0.000993	CcSEcCtD
L-Glutamine—Pain—Cyclosporine—psoriasis	0.000515	0.000993	CcSEcCtD
L-Glutamine—Dry mouth—Triamcinolone—psoriasis	0.000514	0.000991	CcSEcCtD
L-Glutamine—SLC7A8—Transmembrane transport of small molecules—CP—psoriasis	0.000514	0.00234	CbGpPWpGaD
L-Glutamine—Angiopathy—Prednisone—psoriasis	0.000509	0.00098	CcSEcCtD
L-Glutamine—Malaise—Betamethasone—psoriasis	0.000505	0.000974	CcSEcCtD
L-Glutamine—Malaise—Dexamethasone—psoriasis	0.000505	0.000974	CcSEcCtD
L-Glutamine—Oedema—Triamcinolone—psoriasis	0.000504	0.000971	CcSEcCtD
L-Glutamine—Constipation—Mycophenolate mofetil—psoriasis	0.000503	0.000968	CcSEcCtD
L-Glutamine—Pain—Mycophenolate mofetil—psoriasis	0.000503	0.000968	CcSEcCtD
L-Glutamine—Infection—Triamcinolone—psoriasis	0.000501	0.000965	CcSEcCtD
L-Glutamine—Feeling abnormal—Cyclosporine—psoriasis	0.000496	0.000957	CcSEcCtD
L-Glutamine—Insomnia—Prednisolone—psoriasis	0.000496	0.000955	CcSEcCtD
L-Glutamine—ASNS—Metabolism—CYP2S1—psoriasis	0.000496	0.00226	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—CYP2S1—psoriasis	0.000496	0.00226	CbGpPWpGaD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—VEGFA—psoriasis	0.000493	0.00225	CbGpPWpGaD
L-Glutamine—Gastrointestinal pain—Cyclosporine—psoriasis	0.000493	0.000949	CcSEcCtD
L-Glutamine—Dizziness—Mycophenolic acid—psoriasis	0.000492	0.000949	CcSEcCtD
L-Glutamine—Mental disorder—Prednisone—psoriasis	0.000491	0.000947	CcSEcCtD
L-Glutamine—SLC7A8—Transmembrane transport of small molecules—CARM1—psoriasis	0.00049	0.00224	CbGpPWpGaD
L-Glutamine—Malnutrition—Prednisone—psoriasis	0.000488	0.000941	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000488	0.00094	CcSEcCtD
L-Glutamine—Hyperhidrosis—Triamcinolone—psoriasis	0.000487	0.000939	CcSEcCtD
L-Glutamine—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000484	0.000933	CcSEcCtD
L-Glutamine—Insomnia—Hydrocortisone—psoriasis	0.000484	0.000933	CcSEcCtD
L-Glutamine—NADSYN1—Metabolism—CARM1—psoriasis	0.000482	0.0022	CbGpPWpGaD
L-Glutamine—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000481	0.000926	CcSEcCtD
L-Glutamine—Myalgia—Dexamethasone—psoriasis	0.000477	0.000919	CcSEcCtD
L-Glutamine—Myalgia—Betamethasone—psoriasis	0.000477	0.000919	CcSEcCtD
L-Glutamine—Abdominal pain—Cyclosporine—psoriasis	0.000476	0.000918	CcSEcCtD
L-Glutamine—Body temperature increased—Cyclosporine—psoriasis	0.000476	0.000918	CcSEcCtD
L-Glutamine—Vomiting—Mycophenolic acid—psoriasis	0.000473	0.000912	CcSEcCtD
L-Glutamine—Discomfort—Dexamethasone—psoriasis	0.000471	0.000908	CcSEcCtD
L-Glutamine—Discomfort—Betamethasone—psoriasis	0.000471	0.000908	CcSEcCtD
L-Glutamine—Rash—Mycophenolic acid—psoriasis	0.00047	0.000905	CcSEcCtD
L-Glutamine—Dermatitis—Mycophenolic acid—psoriasis	0.000469	0.000904	CcSEcCtD
L-Glutamine—Pain—Prednisolone—psoriasis	0.000469	0.000903	CcSEcCtD
L-Glutamine—Headache—Mycophenolic acid—psoriasis	0.000467	0.000899	CcSEcCtD
L-Glutamine—Pharyngitis—Methotrexate—psoriasis	0.000465	0.000896	CcSEcCtD
L-Glutamine—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000465	0.000895	CcSEcCtD
L-Glutamine—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000465	0.000895	CcSEcCtD
L-Glutamine—Urinary tract disorder—Methotrexate—psoriasis	0.000463	0.000892	CcSEcCtD
L-Glutamine—Fatigue—Hydrocortisone—psoriasis	0.000462	0.000889	CcSEcCtD
L-Glutamine—Urethral disorder—Methotrexate—psoriasis	0.000459	0.000885	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000459	0.000885	CcSEcCtD
L-Glutamine—Pain—Hydrocortisone—psoriasis	0.000458	0.000882	CcSEcCtD
L-Glutamine—Oedema—Dexamethasone—psoriasis	0.000457	0.000881	CcSEcCtD
L-Glutamine—Oedema—Betamethasone—psoriasis	0.000457	0.000881	CcSEcCtD
L-Glutamine—Insomnia—Triamcinolone—psoriasis	0.000456	0.000879	CcSEcCtD
L-Glutamine—Infection—Dexamethasone—psoriasis	0.000454	0.000876	CcSEcCtD
L-Glutamine—Infection—Betamethasone—psoriasis	0.000454	0.000876	CcSEcCtD
L-Glutamine—Ill-defined disorder—Prednisone—psoriasis	0.000453	0.000873	CcSEcCtD
L-Glutamine—Feeling abnormal—Prednisolone—psoriasis	0.000452	0.000871	CcSEcCtD
L-Glutamine—Hypersensitivity—Cyclosporine—psoriasis	0.000444	0.000855	CcSEcCtD
L-Glutamine—Nausea—Mycophenolic acid—psoriasis	0.000442	0.000852	CcSEcCtD
L-Glutamine—Hyperhidrosis—Betamethasone—psoriasis	0.000442	0.000852	CcSEcCtD
L-Glutamine—Hyperhidrosis—Dexamethasone—psoriasis	0.000442	0.000852	CcSEcCtD
L-Glutamine—Feeling abnormal—Hydrocortisone—psoriasis	0.000441	0.00085	CcSEcCtD
L-Glutamine—Malaise—Prednisone—psoriasis	0.00044	0.000848	CcSEcCtD
L-Glutamine—F13A1—Hemostasis—NOS2—psoriasis	0.000439	0.002	CbGpPWpGaD
L-Glutamine—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000438	0.000844	CcSEcCtD
L-Glutamine—Fatigue—Triamcinolone—psoriasis	0.000435	0.000838	CcSEcCtD
L-Glutamine—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000433	0.000834	CcSEcCtD
L-Glutamine—Asthenia—Cyclosporine—psoriasis	0.000432	0.000833	CcSEcCtD
L-Glutamine—Pain—Triamcinolone—psoriasis	0.000431	0.000831	CcSEcCtD
L-Glutamine—Pruritus—Cyclosporine—psoriasis	0.000426	0.000821	CcSEcCtD
L-Glutamine—Angiopathy—Methotrexate—psoriasis	0.000425	0.000819	CcSEcCtD
L-Glutamine—Abdominal pain—Hydrocortisone—psoriasis	0.000423	0.000816	CcSEcCtD
L-Glutamine—Body temperature increased—Hydrocortisone—psoriasis	0.000423	0.000816	CcSEcCtD
L-Glutamine—Asthenia—Mycophenolate mofetil—psoriasis	0.000422	0.000812	CcSEcCtD
L-Glutamine—CCBL1—Metabolism—CARM1—psoriasis	0.000421	0.00192	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—CARM1—psoriasis	0.000421	0.00192	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—CARM1—psoriasis	0.000421	0.00192	CbGpPWpGaD
L-Glutamine—Chills—Methotrexate—psoriasis	0.00042	0.00081	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000417	0.000803	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000417	0.000803	CcSEcCtD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—IL6—psoriasis	0.000417	0.0019	CbGpPWpGaD
L-Glutamine—Pruritus—Mycophenolate mofetil—psoriasis	0.000416	0.000801	CcSEcCtD
L-Glutamine—GFPT2—Metabolism of proteins—LEP—psoriasis	0.000416	0.0019	CbGpPWpGaD
L-Glutamine—Myalgia—Prednisone—psoriasis	0.000416	0.000801	CcSEcCtD
L-Glutamine—Arthralgia—Prednisone—psoriasis	0.000416	0.000801	CcSEcCtD
L-Glutamine—Feeling abnormal—Triamcinolone—psoriasis	0.000415	0.000801	CcSEcCtD
L-Glutamine—Insomnia—Dexamethasone—psoriasis	0.000414	0.000797	CcSEcCtD
L-Glutamine—Insomnia—Betamethasone—psoriasis	0.000414	0.000797	CcSEcCtD
L-Glutamine—Discomfort—Prednisone—psoriasis	0.000411	0.000791	CcSEcCtD
L-Glutamine—Mental disorder—Methotrexate—psoriasis	0.000411	0.000791	CcSEcCtD
L-Glutamine—Malnutrition—Methotrexate—psoriasis	0.000408	0.000786	CcSEcCtD
L-Glutamine—QARS—Gene Expression—VDR—psoriasis	0.000405	0.00185	CbGpPWpGaD
L-Glutamine—Hypersensitivity—Prednisolone—psoriasis	0.000404	0.000778	CcSEcCtD
L-Glutamine—Body temperature increased—Triamcinolone—psoriasis	0.000399	0.000768	CcSEcCtD
L-Glutamine—Dizziness—Cyclosporine—psoriasis	0.000398	0.000768	CcSEcCtD
L-Glutamine—Oedema—Prednisone—psoriasis	0.000398	0.000768	CcSEcCtD
L-Glutamine—Infection—Prednisone—psoriasis	0.000396	0.000763	CcSEcCtD
L-Glutamine—Back pain—Methotrexate—psoriasis	0.000395	0.00076	CcSEcCtD
L-Glutamine—Hypersensitivity—Hydrocortisone—psoriasis	0.000394	0.00076	CcSEcCtD
L-Glutamine—Fatigue—Dexamethasone—psoriasis	0.000394	0.00076	CcSEcCtD
L-Glutamine—Fatigue—Betamethasone—psoriasis	0.000394	0.00076	CcSEcCtD
L-Glutamine—Pain—Dexamethasone—psoriasis	0.000391	0.000754	CcSEcCtD
L-Glutamine—Pain—Betamethasone—psoriasis	0.000391	0.000754	CcSEcCtD
L-Glutamine—Dizziness—Mycophenolate mofetil—psoriasis	0.000389	0.000749	CcSEcCtD
L-Glutamine—Hyperhidrosis—Prednisone—psoriasis	0.000385	0.000742	CcSEcCtD
L-Glutamine—Asthenia—Hydrocortisone—psoriasis	0.000384	0.00074	CcSEcCtD
L-Glutamine—Vomiting—Cyclosporine—psoriasis	0.000383	0.000738	CcSEcCtD
L-Glutamine—Rash—Cyclosporine—psoriasis	0.00038	0.000732	CcSEcCtD
L-Glutamine—Dermatitis—Cyclosporine—psoriasis	0.000379	0.000731	CcSEcCtD
L-Glutamine—Pruritus—Hydrocortisone—psoriasis	0.000379	0.00073	CcSEcCtD
L-Glutamine—Ill-defined disorder—Methotrexate—psoriasis	0.000378	0.000729	CcSEcCtD
L-Glutamine—Headache—Cyclosporine—psoriasis	0.000377	0.000727	CcSEcCtD
L-Glutamine—Feeling abnormal—Betamethasone—psoriasis	0.000377	0.000726	CcSEcCtD
L-Glutamine—Feeling abnormal—Dexamethasone—psoriasis	0.000377	0.000726	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Betamethasone—psoriasis	0.000374	0.000721	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Dexamethasone—psoriasis	0.000374	0.000721	CcSEcCtD
L-Glutamine—Vomiting—Mycophenolate mofetil—psoriasis	0.000374	0.00072	CcSEcCtD
L-Glutamine—Hypersensitivity—Triamcinolone—psoriasis	0.000371	0.000716	CcSEcCtD
L-Glutamine—Rash—Mycophenolate mofetil—psoriasis	0.000371	0.000714	CcSEcCtD
L-Glutamine—Dermatitis—Mycophenolate mofetil—psoriasis	0.00037	0.000713	CcSEcCtD
L-Glutamine—Headache—Mycophenolate mofetil—psoriasis	0.000368	0.000709	CcSEcCtD
L-Glutamine—Malaise—Methotrexate—psoriasis	0.000368	0.000709	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—CAT—psoriasis	0.000364	0.00166	CbGpPWpGaD
L-Glutamine—Musculoskeletal discomfort—Prednisone—psoriasis	0.000363	0.000699	CcSEcCtD
L-Glutamine—Dizziness—Prednisolone—psoriasis	0.000363	0.000699	CcSEcCtD
L-Glutamine—Asthenia—Triamcinolone—psoriasis	0.000362	0.000697	CcSEcCtD
L-Glutamine—Abdominal pain—Betamethasone—psoriasis	0.000362	0.000697	CcSEcCtD
L-Glutamine—Abdominal pain—Dexamethasone—psoriasis	0.000362	0.000697	CcSEcCtD
L-Glutamine—Body temperature increased—Betamethasone—psoriasis	0.000362	0.000697	CcSEcCtD
L-Glutamine—Body temperature increased—Dexamethasone—psoriasis	0.000362	0.000697	CcSEcCtD
L-Glutamine—ASNS—Metabolism of proteins—ACE—psoriasis	0.000361	0.00165	CbGpPWpGaD
L-Glutamine—Insomnia—Prednisone—psoriasis	0.00036	0.000694	CcSEcCtD
L-Glutamine—Nausea—Cyclosporine—psoriasis	0.000358	0.00069	CcSEcCtD
L-Glutamine—Pruritus—Triamcinolone—psoriasis	0.000357	0.000687	CcSEcCtD
L-Glutamine—Dizziness—Hydrocortisone—psoriasis	0.000354	0.000682	CcSEcCtD
L-Glutamine—Nausea—Mycophenolate mofetil—psoriasis	0.000349	0.000673	CcSEcCtD
L-Glutamine—Myalgia—Methotrexate—psoriasis	0.000347	0.000669	CcSEcCtD
L-Glutamine—Chest pain—Methotrexate—psoriasis	0.000347	0.000669	CcSEcCtD
L-Glutamine—Arthralgia—Methotrexate—psoriasis	0.000347	0.000669	CcSEcCtD
L-Glutamine—Rash—Prednisolone—psoriasis	0.000346	0.000666	CcSEcCtD
L-Glutamine—Dermatitis—Prednisolone—psoriasis	0.000345	0.000665	CcSEcCtD
L-Glutamine—Fatigue—Prednisone—psoriasis	0.000343	0.000662	CcSEcCtD
L-Glutamine—Headache—Prednisolone—psoriasis	0.000343	0.000662	CcSEcCtD
L-Glutamine—Discomfort—Methotrexate—psoriasis	0.000343	0.000661	CcSEcCtD
L-Glutamine—Constipation—Prednisone—psoriasis	0.000341	0.000656	CcSEcCtD
L-Glutamine—Vomiting—Hydrocortisone—psoriasis	0.00034	0.000656	CcSEcCtD
L-Glutamine—CAD—Metabolism—CARM1—psoriasis	0.00034	0.00155	CbGpPWpGaD
L-Glutamine—Rash—Hydrocortisone—psoriasis	0.000338	0.000651	CcSEcCtD
L-Glutamine—Dermatitis—Hydrocortisone—psoriasis	0.000337	0.00065	CcSEcCtD
L-Glutamine—Headache—Hydrocortisone—psoriasis	0.000335	0.000646	CcSEcCtD
L-Glutamine—Dizziness—Triamcinolone—psoriasis	0.000333	0.000642	CcSEcCtD
L-Glutamine—Infection—Methotrexate—psoriasis	0.000331	0.000637	CcSEcCtD
L-Glutamine—Feeling abnormal—Prednisone—psoriasis	0.000328	0.000633	CcSEcCtD
L-Glutamine—Asthenia—Dexamethasone—psoriasis	0.000328	0.000632	CcSEcCtD
L-Glutamine—Asthenia—Betamethasone—psoriasis	0.000328	0.000632	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Prednisone—psoriasis	0.000326	0.000628	CcSEcCtD
L-Glutamine—Nausea—Prednisolone—psoriasis	0.000326	0.000627	CcSEcCtD
L-Glutamine—GMPS—Metabolism—CAT—psoriasis	0.000324	0.00148	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—CAT—psoriasis	0.000324	0.00148	CbGpPWpGaD
L-Glutamine—Pruritus—Dexamethasone—psoriasis	0.000324	0.000624	CcSEcCtD
L-Glutamine—Pruritus—Betamethasone—psoriasis	0.000324	0.000624	CcSEcCtD
L-Glutamine—Hyperhidrosis—Methotrexate—psoriasis	0.000322	0.00062	CcSEcCtD
L-Glutamine—Vomiting—Triamcinolone—psoriasis	0.000321	0.000618	CcSEcCtD
L-Glutamine—Nausea—Hydrocortisone—psoriasis	0.000318	0.000613	CcSEcCtD
L-Glutamine—Rash—Triamcinolone—psoriasis	0.000318	0.000613	CcSEcCtD
L-Glutamine—Dermatitis—Triamcinolone—psoriasis	0.000318	0.000612	CcSEcCtD
L-Glutamine—Headache—Triamcinolone—psoriasis	0.000316	0.000609	CcSEcCtD
L-Glutamine—Body temperature increased—Prednisone—psoriasis	0.000315	0.000607	CcSEcCtD
L-Glutamine—Abdominal pain—Prednisone—psoriasis	0.000315	0.000607	CcSEcCtD
L-Glutamine—PPAT—Metabolism—CARM1—psoriasis	0.000311	0.00142	CbGpPWpGaD
L-Glutamine—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000303	0.000584	CcSEcCtD
L-Glutamine—Dizziness—Dexamethasone—psoriasis	0.000302	0.000583	CcSEcCtD
L-Glutamine—Dizziness—Betamethasone—psoriasis	0.000302	0.000583	CcSEcCtD
L-Glutamine—Insomnia—Methotrexate—psoriasis	0.000301	0.00058	CcSEcCtD
L-Glutamine—Nausea—Triamcinolone—psoriasis	0.000299	0.000577	CcSEcCtD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—CP—psoriasis	0.000298	0.00136	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—CAT—psoriasis	0.000297	0.00135	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—HLA-A—psoriasis	0.000295	0.00134	CbGpPWpGaD
L-Glutamine—Hypersensitivity—Prednisone—psoriasis	0.000293	0.000566	CcSEcCtD
L-Glutamine—Vomiting—Betamethasone—psoriasis	0.000291	0.00056	CcSEcCtD
L-Glutamine—Vomiting—Dexamethasone—psoriasis	0.000291	0.00056	CcSEcCtD
L-Glutamine—Rash—Betamethasone—psoriasis	0.000288	0.000556	CcSEcCtD
L-Glutamine—Rash—Dexamethasone—psoriasis	0.000288	0.000556	CcSEcCtD
L-Glutamine—Dermatitis—Dexamethasone—psoriasis	0.000288	0.000555	CcSEcCtD
L-Glutamine—Dermatitis—Betamethasone—psoriasis	0.000288	0.000555	CcSEcCtD
L-Glutamine—Fatigue—Methotrexate—psoriasis	0.000287	0.000553	CcSEcCtD
L-Glutamine—Headache—Dexamethasone—psoriasis	0.000287	0.000552	CcSEcCtD
L-Glutamine—Headache—Betamethasone—psoriasis	0.000287	0.000552	CcSEcCtD
L-Glutamine—Asthenia—Prednisone—psoriasis	0.000286	0.000551	CcSEcCtD
L-Glutamine—Pain—Methotrexate—psoriasis	0.000285	0.000549	CcSEcCtD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—CARM1—psoriasis	0.000284	0.0013	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—APOE—psoriasis	0.000283	0.00129	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—PPARG—psoriasis	0.000282	0.00129	CbGpPWpGaD
L-Glutamine—Pruritus—Prednisone—psoriasis	0.000282	0.000543	CcSEcCtD
L-Glutamine—GFPT2—Metabolism of proteins—CXCL8—psoriasis	0.000276	0.00126	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—APOE—psoriasis	0.000275	0.00126	CbGpPWpGaD
L-Glutamine—Feeling abnormal—Methotrexate—psoriasis	0.000274	0.000529	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Methotrexate—psoriasis	0.000272	0.000525	CcSEcCtD
L-Glutamine—Nausea—Betamethasone—psoriasis	0.000272	0.000524	CcSEcCtD
L-Glutamine—Nausea—Dexamethasone—psoriasis	0.000272	0.000524	CcSEcCtD
L-Glutamine—Dizziness—Prednisone—psoriasis	0.000263	0.000508	CcSEcCtD
L-Glutamine—Body temperature increased—Methotrexate—psoriasis	0.000263	0.000507	CcSEcCtD
L-Glutamine—Abdominal pain—Methotrexate—psoriasis	0.000263	0.000507	CcSEcCtD
L-Glutamine—CCBL1—Metabolism—CAT—psoriasis	0.000259	0.00118	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—CAT—psoriasis	0.000259	0.00118	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—CAT—psoriasis	0.000259	0.00118	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—HLA-A—psoriasis	0.000258	0.00118	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—NOS2—psoriasis	0.000256	0.00117	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—VEGFA—psoriasis	0.000254	0.00116	CbGpPWpGaD
L-Glutamine—Vomiting—Prednisone—psoriasis	0.000253	0.000488	CcSEcCtD
L-Glutamine—SLC7A8—Hemostasis—NOS2—psoriasis	0.000252	0.00115	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—APOE—psoriasis	0.000252	0.00115	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—APOE—psoriasis	0.000252	0.00115	CbGpPWpGaD
L-Glutamine—Rash—Prednisone—psoriasis	0.000251	0.000484	CcSEcCtD
L-Glutamine—Dermatitis—Prednisone—psoriasis	0.000251	0.000484	CcSEcCtD
L-Glutamine—Headache—Prednisone—psoriasis	0.00025	0.000481	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—PPARG—psoriasis	0.000246	0.00112	CbGpPWpGaD
L-Glutamine—Hypersensitivity—Methotrexate—psoriasis	0.000245	0.000473	CcSEcCtD
L-Glutamine—GLUL—Metabolism—CARM1—psoriasis	0.000242	0.0011	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—CARM1—psoriasis	0.000242	0.0011	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—APOE—psoriasis	0.000241	0.0011	CbGpPWpGaD
L-Glutamine—Asthenia—Methotrexate—psoriasis	0.000239	0.00046	CcSEcCtD
L-Glutamine—Nausea—Prednisone—psoriasis	0.000237	0.000456	CcSEcCtD
L-Glutamine—Pruritus—Methotrexate—psoriasis	0.000236	0.000454	CcSEcCtD
L-Glutamine—NADSYN1—Metabolism—APOE—psoriasis	0.00023	0.00105	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—LEP—psoriasis	0.000224	0.00102	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—NOS2—psoriasis	0.000224	0.00102	CbGpPWpGaD
L-Glutamine—Dizziness—Methotrexate—psoriasis	0.00022	0.000424	CcSEcCtD
L-Glutamine—GMPS—Metabolism—PPARG—psoriasis	0.000219	0.001	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PPARG—psoriasis	0.000219	0.001	CbGpPWpGaD
L-Glutamine—Vomiting—Methotrexate—psoriasis	0.000212	0.000408	CcSEcCtD
L-Glutamine—NADSYN1—Disease—TYK2—psoriasis	0.00021	0.000958	CbGpPWpGaD
L-Glutamine—Rash—Methotrexate—psoriasis	0.00021	0.000404	CcSEcCtD
L-Glutamine—Dermatitis—Methotrexate—psoriasis	0.00021	0.000404	CcSEcCtD
L-Glutamine—CAD—Metabolism—CAT—psoriasis	0.000209	0.000954	CbGpPWpGaD
L-Glutamine—Headache—Methotrexate—psoriasis	0.000209	0.000402	CcSEcCtD
L-Glutamine—CCBL1—Metabolism—APOE—psoriasis	0.000201	0.000919	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—APOE—psoriasis	0.000201	0.000919	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—APOE—psoriasis	0.000201	0.000919	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PPARG—psoriasis	0.000201	0.000916	CbGpPWpGaD
L-Glutamine—Nausea—Methotrexate—psoriasis	0.000198	0.000381	CcSEcCtD
L-Glutamine—F13A1—Hemostasis—TP53—psoriasis	0.000192	0.000876	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—CAT—psoriasis	0.000191	0.000872	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—CD4—psoriasis	0.00019	0.000867	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—TYK2—psoriasis	0.000184	0.000838	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PPARG—psoriasis	0.000175	0.000801	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PPARG—psoriasis	0.000175	0.000801	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PPARG—psoriasis	0.000175	0.000801	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CD4—psoriasis	0.000166	0.000758	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—APOE—psoriasis	0.000162	0.000741	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—CXCL8—psoriasis	0.000149	0.000681	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—CAT—psoriasis	0.000149	0.000679	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—CAT—psoriasis	0.000149	0.000679	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—APOE—psoriasis	0.000148	0.000678	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—STAT3—psoriasis	0.000147	0.000671	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—VEGFA—psoriasis	0.000146	0.000666	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PPARG—psoriasis	0.000141	0.000645	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PPARG—psoriasis	0.000129	0.00059	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—STAT3—psoriasis	0.000129	0.000587	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—APOE—psoriasis	0.000116	0.000528	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—APOE—psoriasis	0.000116	0.000528	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—TP53—psoriasis	0.00011	0.000503	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—IL6—psoriasis	0.000103	0.000469	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PPARG—psoriasis	0.000101	0.00046	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PPARG—psoriasis	0.000101	0.00046	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—IL6—psoriasis	8.98e-05	0.00041	CbGpPWpGaD
